Facebook
Twitter
LinkedIn
Forward
13th International Pediatric Intestinal Failure and Rehabilitation Symposium
Join us for the 13th International Pediatric Intestinal Failure and Rehabilitation Symposium from Thursday, Sept. 26, to Saturday, Sept. 28, 2024, at the Wyndham Grand Pittsburgh in Pittsburgh, Pa.
The biannual event is sponsored by UPMC Children’s Hospital of Pittsburgh.
This global meeting is designed to bring together international and national experts in the multidisciplinary care of the intestinal failure patient. This year’s theme, Intestinal Failure 360°, will explore a multifaceted view at all aspects of intestinal failure and transplant from birth to adulthood.
So much has transpired in the past two decades, and this meeting will celebrate the tremendous advances in medical and surgical care for the intestinal failure patient while addressing the challenges that face the field. The Primer and the Symposium will address the latest developments in etiology, pathophysiology, surgical and nonsurgical therapies, quality-of-life, and outcomes-based work in the field.
PIFRS integrates medical and surgical dialogue to help build off the dramatic interdisciplinary work that has characterized intestinal failure management. Global leaders in the field will set the stage for important next steps and networking.
Target Audience
This global meeting is designed to bring together pediatric gastroenterologists, surgeons, hepatologists, scientists and allied health professionals who are dedicated to the care of children with intestinal failure.
Faculty Disclosure:
All individuals in a position to control the content of this education activity have disclosed all financial relationships with any companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. All of the relevant financial relationships for the individuals listed below have been mitigated.
Name | Company Name | Nature of Relationship | Mitigation Strategy |
Selma Feldman Witchel | Neurocrine Biosciences | Grant/Research Support | The relationship has ended. |
Swapna Kakani | Ironwood Pharmaceuticals (Vectiv Bio) | Consultant | The course director or designee attests that the content has been reviewed and found to be evidence-based and free of commercial bias (e.g., peer-reviewed literature, adhering to evidence-based practice guidelines). |
Swapna Kakani | Takeda Pharmaceuticals | Consultant | The relationship has ended. |
Swapna Kakani | BBraun Medical | Consultant | The relationship has ended. |
Swapna Kakani | QSynthesis CE Program Presenter | Speakers’ Bureau | The relationship has ended. |
Swapna Kakani | Medscape CE Program Writer | Speakers’ Bureau | The relationship has ended. |
Inez Martincevic | Mirum Pharmaceuticals | Grant/Research Support | The course director or designee attests that the content has been reviewed and found to be evidence-based and free of commercial bias (e.g., peer-reviewed literature, adhering to evidence-based practice guidelines). |
Inez Martincevic | Allied health advisory board | Consultant | The course director or designee attests that the content has been reviewed and found to be evidence-based and free of commercial bias (e.g., peer-reviewed literature, adhering to evidence-based practice guidelines). |
David Mercer | Zealand Pharmaceuticals | Grant/Research Support | The course director or designee attests that the content has been reviewed and found to be evidence-based and free of commercial bias (e.g., peer-reviewed literature, adhering to evidence-based practice guidelines). |
David Mercer | Takeda | Grant/Research Support | The course director or designee attests that the content has been reviewed and found to be evidence-based and free of commercial bias (e.g., peer-reviewed literature, adhering to evidence-based practice guidelines). |
David Mercer | VectivBio | Grant/Research Support | The course director or designee attests that the content has been reviewed and found to be evidence-based and free of commercial bias (e.g., peer-reviewed literature, adhering to evidence-based practice guidelines). |
David Mercer | The Insides Company | Grant/Research Support | The course director or designee attests that the content has been reviewed and found to be evidence-based and free of commercial bias (e.g., peer-reviewed literature, adhering to evidence-based practice guidelines). |
David Mercer | Zealand Pharmaceuticals | Consultant | The course director or designee attests that the content has been reviewed and found to be evidence-based and free of commercial bias (e.g., peer-reviewed literature, adhering to evidence-based practice guidelines). |
Simon Horslen | Mirum | Grant/Research Support | The course director or designee attests that the content has been reviewed and found to be evidence-based and free of commercial bias (e.g., peer-reviewed literature, adhering to evidence-based practice guidelines). |
Simon Horslen | Ipsen/Albireo | Consultant | The course director or designee attests that the content has been reviewed and found to be evidence-based and free of commercial bias (e.g., peer-reviewed literature, adhering to evidence-based practice guidelines). |
Jessica Y. Allen | Ironwood Pharmaceuticals Inc | Consultant | The course director or designee attests that the content has been reviewed and found to be evidence-based and free of commercial bias (e.g., peer-reviewed literature, adhering to evidence-based practice guidelines). |
Samuel Kocoshis | Ironwood Pharmaceuticals Inc | Grant/Research Support | The course director or designee attests that the content has been reviewed and found to be evidence-based and free of commercial bias (e.g., peer-reviewed literature, adhering to evidence-based practice guidelines). |
Samuel Kocoshis | Protara Pharmaceuticals | Grant/Research Support | The course director or designee attests that the content has been reviewed and found to be evidence-based and free of commercial bias (e.g., peer-reviewed literature, adhering to evidence-based practice guidelines). |
Samuel Kocoshis | Takeda Pharmaceuticals | Grant/Research Support | The relationship has ended. |
Samuel Kocoshis | Zealand Pharmaceuticals | Consultant | The course director or designee attests that the content has been reviewed and found to be evidence-based and free of commercial bias (e.g., peer-reviewed literature, adhering to evidence-based practice guidelines). |
Samuel Kocoshis | Abbott Nutrition | Speakers’ Bureau | The course director or designee attests that the content has been reviewed and found to be evidence-based and free of commercial bias (e.g., peer-reviewed literature, adhering to evidence-based practice guidelines). |
Anita Nucci | Takeda Pharmaceuticals | Grant/Research Support | The course director or designee attests that the content has been reviewed and found to be evidence-based and free of commercial bias (e.g., peer-reviewed literature, adhering to evidence-based practice guidelines). |
Jacqueline Kreutzer MD | Edwards LifeSciences | Grant/Research Support | The course director or designee attests that the content has been reviewed and found to be evidence-based and free of commercial bias (e.g., peer-reviewed literature, adhering to evidence-based practice guidelines). |
Jacqueline Kreutzer MD | Medtronic | Grant/Research Support | The course director or designee attests that the content has been reviewed and found to be evidence-based and free of commercial bias (e.g., peer-reviewed literature, adhering to evidence-based practice guidelines). |
Jacqueline Kreutzer MD | Medtronic | Consultant | The course director or designee attests that the content has been reviewed and found to be evidence-based and free of commercial bias (e.g., peer-reviewed literature, adhering to evidence-based practice guidelines). |
Lisa A. Coscia | Veloxis Pharmaceuticals | Grant/Research Support | The course director or designee attests that the content has been reviewed and found to be evidence-based and free of commercial bias (e.g., peer-reviewed literature, adhering to evidence-based practice guidelines). |
Lisa A. Coscia | Astellas Pharmaceuticals | Grant/Research Support | The course director or designee attests that the content has been reviewed and found to be evidence-based and free of commercial bias (e.g., peer-reviewed literature, adhering to evidence-based practice guidelines). |
Girish Gupte | IPSEN (investigator initiated study) | Grant/Research Support | The course director or designee attests that the content has been reviewed and found to be evidence-based and free of commercial bias (e.g., peer-reviewed literature, adhering to evidence-based practice guidelines). |
Vikram Raghu | Alcresta | Grant/Research Support | The course director or designee attests that the content has been reviewed and found to be evidence-based and free of commercial bias (e.g., peer-reviewed literature, adhering to evidence-based practice guidelines). |
Vikram Raghu | Takeda | Consultant | The relationship has ended. |
Kathleen Gura | Alcresta | Grant/Research Support | The course director or designee attests that the content has been reviewed and found to be evidence-based and free of commercial bias (e.g., peer-reviewed literature, adhering to evidence-based practice guidelines). |
Kathleen Gura | NorthSea Therapeutics | Grant/Research Support | The course director or designee attests that the content has been reviewed and found to be evidence-based and free of commercial bias (e.g., peer-reviewed literature, adhering to evidence-based practice guidelines). |
Kathleen Gura | Fresenius Kabi | Grant/Research Support | The course director or designee attests that the content has been reviewed and found to be evidence-based and free of commercial bias (e.g., peer-reviewed literature, adhering to evidence-based practice guidelines). |
Kathleen Gura | Fresenius Kabi | Consultant | The course director or designee attests that the content has been reviewed and found to be evidence-based and free of commercial bias (e.g., peer-reviewed literature, adhering to evidence-based practice guidelines). |
Kathleen Gura | NorthSea Therapeutics | Consultant | The course director or designee attests that the content has been reviewed and found to be evidence-based and free of commercial bias (e.g., peer-reviewed literature, adhering to evidence-based practice guidelines). |
Kathleen Gura | Alcresta | Consultant | The course director or designee attests that the content has been reviewed and found to be evidence-based and free of commercial bias (e.g., peer-reviewed literature, adhering to evidence-based practice guidelines). |
Kathleen Gura | Lexicomp | Consultant | The course director or designee attests that the content has been reviewed and found to be evidence-based and free of commercial bias (e.g., peer-reviewed literature, adhering to evidence-based practice guidelines). |
Kathleen Gura | Takeda | Consultant | The course director or designee attests that the content has been reviewed and found to be evidence-based and free of commercial bias (e.g., peer-reviewed literature, adhering to evidence-based practice guidelines). |
Kathleen Gura | Mead Johnson/Reckitt | Consultant | The course director or designee attests that the content has been reviewed and found to be evidence-based and free of commercial bias (e.g., peer-reviewed literature, adhering to evidence-based practice guidelines). |
Kathleen Gura | Otsuka Pharmaceutical Company | Consultant | The course director or designee attests that the content has been reviewed and found to be evidence-based and free of commercial bias (e.g., peer-reviewed literature, adhering to evidence-based practice guidelines). |
Kathleen Gura | Lexicomp/UpToDate | Other | The course director or designee attests that the content has been reviewed and found to be evidence-based and free of commercial bias (e.g., peer-reviewed literature, adhering to evidence-based practice guidelines). |
Kathleen Gura | Fresenius Kabi | Other | The course director or designee attests that the content has been reviewed and found to be evidence-based and free of commercial bias (e.g., peer-reviewed literature, adhering to evidence-based practice guidelines). |
Marie L Neumann | Zealand Pharma | Grant/Research Support | The course director or designee attests that the content has been reviewed and found to be evidence-based and free of commercial bias (e.g., peer-reviewed literature, adhering to evidence-based practice guidelines). |
Marie L Neumann | Takeda Pharmaceuticals | Consultant | The course director or designee attests that the content has been reviewed and found to be evidence-based and free of commercial bias (e.g., peer-reviewed literature, adhering to evidence-based practice guidelines). |
Marie L Neumann | Ironwood Pharmaceuticals | Consultant | The course director or designee attests that the content has been reviewed and found to be evidence-based and free of commercial bias (e.g., peer-reviewed literature, adhering to evidence-based practice guidelines). |
Marie L Neumann | Optum Health Education | Speakers’ Bureau | The course director or designee attests that the content has been reviewed and found to be evidence-based and free of commercial bias (e.g., peer-reviewed literature, adhering to evidence-based practice guidelines). |
Yaron Avitzur | Zealand Pharma | Grant/Research Support | The course director or designee attests that the content has been reviewed and found to be evidence-based and free of commercial bias (e.g., peer-reviewed literature, adhering to evidence-based practice guidelines). |
Yaron Avitzur | VectivBio | Grant/Research Support | The course director or designee attests that the content has been reviewed and found to be evidence-based and free of commercial bias (e.g., peer-reviewed literature, adhering to evidence-based practice guidelines). |
Yaron Avitzur | SterileCare | Grant/Research Support | The course director or designee attests that the content has been reviewed and found to be evidence-based and free of commercial bias (e.g., peer-reviewed literature, adhering to evidence-based practice guidelines). |
Yaron Avitzur | Takeda | Grant/Research Support | The course director or designee attests that the content has been reviewed and found to be evidence-based and free of commercial bias (e.g., peer-reviewed literature, adhering to evidence-based practice guidelines). |
Yaron Avitzur | Zealand Pharma | Consultant | The course director or designee attests that the content has been reviewed and found to be evidence-based and free of commercial bias (e.g., peer-reviewed literature, adhering to evidence-based practice guidelines). |
Yaron Avitzur | VectivBio | Consultant | The course director or designee attests that the content has been reviewed and found to be evidence-based and free of commercial bias (e.g., peer-reviewed literature, adhering to evidence-based practice guidelines). |
Yaron Avitzur | Takeda | Other: Non restricted grant | The course director or designee attests that the content has been reviewed and found to be evidence-based and free of commercial bias (e.g., peer-reviewed literature, adhering to evidence-based practice guidelines). |
Yaron Avitzur | SterileCare | Other: DSMB Chair | The course director or designee attests that the content has been reviewed and found to be evidence-based and free of commercial bias (e.g., peer-reviewed literature, adhering to evidence-based practice guidelines). |
Jacqueline Wessel | Alcresta | Consultant | The relationship has ended. |
Jacqueline Wessel | Abbott Nutrition | Speakers’ Bureau | The course director or designee attests that the content has been reviewed and found to be evidence-based and free of commercial bias (e.g., peer-reviewed literature, adhering to evidence-based practice guidelines). |
Marie Luise Neumann | Zealand Pharma | Grant/Research Support | The course director or designee attests that the content has been reviewed and found to be evidence-based and free of commercial bias (e.g., peer-reviewed literature, adhering to evidence-based practice guidelines). |
Marie Luise Neumann | Takeda Pharmaceuticals | Consultant | The relationship has ended. |
Marie Luise Neumann | ironwood Pharmaceuticals | Consultant | The course director or designee attests that the content has been reviewed and found to be evidence-based and free of commercial bias (e.g., peer-reviewed literature, adhering to evidence-based practice guidelines). |
Marie Luise Neumann | Optum Health Education | Speakers’ Bureau | The course director or designee attests that the content has been reviewed and found to be evidence-based and free of commercial bias (e.g., peer-reviewed literature, adhering to evidence-based practice guidelines). |
Yaron Avitzur | Takeda LTD | Grant/Research Support | The course director or designee attests that the content has been reviewed and found to be evidence-based and free of commercial bias (e.g., peer-reviewed |
Yaron Avitzur | Zealand Pharma | Consultant | The course director or designee attests that the content has been reviewed and found to be evidence-based and free of commercial bias (e.g., peer-reviewed |
Yaron Avitzur | VectivBio | Consultant | The course director or designee attests that the content has been reviewed and found to be evidence-based and free of commercial bias (e.g., peer-reviewed |
Yaron Avitzur | SterileCare | Consultant | The relationship has ended. |
Dana Boctor | Takeda Education Grant | Grant/Research Support | The course director or designee attests that the content has been reviewed and found to be evidence-based and free of commercial bias (e.g., peer-reviewed |
Conrad Cole | SterileCare | Grant/Research Support | The course director or designee attests that the content has been reviewed and found to be evidence-based and free of commercial bias (e.g., peer-reviewed |
Douglas G Farmer | Takeda Pharmaceuticals | Consultant | The course director or designee attests that the content has been reviewed and found to be evidence-based and free of commercial bias (e.g., peer-reviewed |
Glenda Courtney-Martin | Mead Johnson & Reckitt | Consultant | The relationship has ended. |
Maria Cristina Segovia | NORTHSEA | Grant/Research Support | The course director or designee attests that the content has been reviewed and found to be evidence-based and free of commercial bias (e.g., peer-reviewed |
Maria Cristina Segovia | Takeda Pharmaceutical Company | Consultant | The course director or designee attests that the content has been reviewed and found to be evidence-based and free of commercial bias (e.g., peer-reviewed |
Kelly Tappenden | Takeda Pharmaceuticals | Consultant | The course director or designee attests that the content has been reviewed and found to be evidence-based and free of commercial bias (e.g., peer-reviewed |
Kelly Tappenden | Nestle Nutrition | Consultant | The course director or designee attests that the content has been reviewed and found to be evidence-based and free of commercial bias (e.g., peer-reviewed |
Kelly Tappenden | Abbott Nutrition | Consultant | The course director or designee attests that the content has been reviewed and found to be evidence-based and free of commercial bias (e.g., peer-reviewed |
Kelly Tappenden | Nutricia | Consultant | The course director or designee attests that the content has been reviewed and found to be evidence-based and free of commercial bias (e.g., peer-reviewed |
Kathleen Guru | Alcresta | Grant/Research Support | The course director or designee attests that the content has been reviewed and found to be evidence-based and free of commercial bias (e.g., peer-reviewed |
Kathleen Guru | NorthSea Therapeutics | Grant/Research Support | The course director or designee attests that the content has been reviewed and found to be evidence-based and free of commercial bias (e.g., peer-reviewed |
Kathleen Guru | Fresenius Kabi | Grant/Research Support | The course director or designee attests that the content has been reviewed and found to be evidence-based and free of commercial bias (e.g., peer-reviewed |
Kathleen Guru | SterileCare | Grant/Research Support | The course director or designee attests that the content has been reviewed and found to be evidence-based and free of commercial bias (e.g., peer-reviewed |
Kathleen Guru | Alcresta | Consultant | The course director or designee attests that the content has been reviewed and found to be evidence-based and free of commercial bias (e.g., peer-reviewed |
Kathleen Guru | NorthSea Therapeutics | Consultant | The course director or designee attests that the content has been reviewed and found to be evidence-based and free of commercial bias (e.g., peer-reviewed |
Kathleen Guru | Fresnius Kabi | Consultant | The course director or designee attests that the content has been reviewed and found to be evidence-based and free of commercial bias (e.g., peer-reviewed |
Kathleen Guru | Otsuka | Consultant | The course director or designee attests that the content has been reviewed and found to be evidence-based and free of commercial bias (e.g., peer-reviewed |
Kathleen Guru | Takeda | Consultant | The course director or designee attests that the content has been reviewed and found to be evidence-based and free of commercial bias (e.g., peer-reviewed |
Kathleen Guru | Reckitt | Consultant | The course director or designee attests that the content has been reviewed and found to be evidence-based and free of commercial bias (e.g., peer-reviewed |
Kathleen Guru | Baxter | Consultant | The course director or designee attests that the content has been reviewed and found to be evidence-based and free of commercial bias (e.g., peer-reviewed |
Kathleen Guru | Fresnius Kabi | Other: royalities | The course director or designee attests that the content has been reviewed and found to be evidence-based and free of commercial bias (e.g., peer-reviewed |
Kathleen Guru | UpToDate | Other: royalties | The course director or designee attests that the content has been reviewed and found to be evidence-based and free of commercial bias (e.g., peer-reviewed |
Christina Belza | SterileCare Inc. | Consultant | The course director or designee attests that the content has been reviewed and found to be evidence-based and free of commercial bias (e.g., peer-reviewed |
David Hackam | Abbot Nutrition | Grant/Research Support | The course director or designee attests that the content has been reviewed and found to be evidence-based and free of commercial bias (e.g., peer-reviewed |
David Hackam | Siotta Therapeutics | Grant/Research Support | The course director or designee attests that the content has been reviewed and found to be evidence-based and free of commercial bias (e.g., peer-reviewed |
Hilary Bashaw | Takeda | Grant/Research Support | The relationship has ended. |
Hilary Bashaw | Regeneron Pharmaceutical Company | Grant/Research Support | The relationship has ended. |
Hilary Bashaw | QCL Medical | Grant/Research Support | The relationship has ended. |
Paul Wales | Takeda | Grant/Research Support | The course director or designee attests that the content has been reviewed and found to be evidence-based and free of commercial bias (e.g., peer-reviewed |
Paul Wales | Baxter | Grant/Research Support | The course director or designee attests that the content has been reviewed and found to be evidence-based and free of commercial bias (e.g., peer-reviewed |
Paul Wales | SterileCare | Grant/Research Support | The course director or designee attests that the content has been reviewed and found to be evidence-based and free of commercial bias (e.g., peer-reviewed |
Paul Wales | Zealand Pharma | Grant/Research Support | The course director or designee attests that the content has been reviewed and found to be evidence-based and free of commercial bias (e.g., peer-reviewed |
Deb Sudan | Vectiv-Bio | Grant/Research Support | The course director or designee attests that the content has been reviewed and found to be evidence-based and free of commercial bias (e.g., peer-reviewed |
Deb Sudan | CareDx Inc | Grant/Research Support | The course director or designee attests that the content has been reviewed and found to be evidence-based and free of commercial bias (e.g., peer-reviewed |
Deb Sudan | Paragonix | Grant/Research Support | The course director or designee attests that the content has been reviewed and found to be evidence-based and free of commercial bias (e.g., peer-reviewed |
Deb Sudan | Transmedics | Grant/Research Support | The course director or designee attests that the content has been reviewed and found to be evidence-based and free of commercial bias (e.g., peer-reviewed |
Deb Sudan | Organox LTD | Grant/Research Support | The course director or designee attests that the content has been reviewed and found to be evidence-based and free of commercial bias (e.g., peer-reviewed |
Valeria Cohran | Takeda | Grant/Research Support | The course director or designee attests that the content has been reviewed and found to be evidence-based and free of commercial bias (e.g., peer-reviewed |
Valeria Cohran | Alcresta Therapeutics | Consultant | The course director or designee attests that the content has been reviewed and found to be evidence-based and free of commercial bias (e.g., peer-reviewed |
Valeria Cohran | Takeda | Consultant | The course director or designee attests that the content has been reviewed and found to be evidence-based and free of commercial bias (e.g., peer-reviewed |
Valeria Cohran | Takeda | Speakers’ Bureau | The course director or designee attests that the content has been reviewed and found to be evidence-based and free of commercial bias (e.g., peer-reviewed |
Valeria Cohran | Abbott Nutrition | Speakers’ Bureau | The course director or designee attests that the content has been reviewed and found to be evidence-based and free of commercial bias (e.g., peer-reviewed |
Valeria Cohran | Alcresta Therapeutics | Speakers’ Bureau | The course director or designee attests that the content has been reviewed and found to be evidence-based and free of commercial bias (e.g., peer-reviewed |
Girish Gupte | ISPEN | Grant/Research Support | The course director or designee attests that the content has been reviewed and found to be evidence-based and free of commercial bias (e.g., peer-reviewed |
No other members of the planning committee, speakers, presenters, authors, content reviewers and/or anyone else in a position to control the content of this education activity have relevant financial relationships with any companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
In support of improving patient care, the University of Pittsburgh is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physician (CME)
The University of Pittsburgh designates this live activity for a maximum of 19.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nursing (CNE)
The maximum number of hours awarded for this Continuing Nursing Education activity is 19.0 contact hours.
Other health care professionals will receive a certificate of attendance confirming the number of contact hours commensurate with the extent of participation in this activity.
Social Work (ASWB)
As a Jointly Accredited Organization, the University of Pittsburgh is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses, are approved under this program. Regulatory boards are the final authority on courses accepted for continuing education credit. Social workers completing this course receive 19.0 continuing education credits
Prior approval for continuing professional education hours for Registered Dietitians has been requested with the Commission on Dietetic Registration. A certificate of attendance will be provided at the conclusion of the symposium.
Available Credit
- 19.00 AMA PRA Category 1 Credit™The University of Pittsburgh School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
- 19.00 ANCCUPMC Provider Unit is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation
- 19.00 ASWB
- 19.00 Attendance
For questions regarding the conference or registration, please contact:
Sarah Gould-Stotts
Office: 817-907-9873
Email: sarah@thehuttongroup.com
For questions regarding exhibiting or sponsorships, please contact:
Dawn Wilkerson
Office: 412-692-6428
Email: dawn.wilkerson2@upmc.edu